• 我要登录|
  • 免费注册
    |
  • 我的丁香通
    • 企业机构:
    • 成为企业机构
    • 个人用户:
    • 个人中心
  • 移动端
    移动端
丁香通 logo丁香实验_LOGO
搜实验

    大家都在搜

      大家都在搜

        0 人通过求购买到了急需的产品
        免费发布求购
        发布求购
        点赞
        收藏
        wx-share
        分享

        Dual-Incision Assays for Nucleotide Excision Repair Using DNA with a Lesion at a Specific Site

        互联网

        581
        Cells remove a wide array of potentially toxic and mutagenic lesions from their genomes by a major repair pathway called nucleotide excision repair (NER). This repair process involves a multiprotein nuclease complex that incises a damaged DNA strand on the 5′- and 3′-sides of a lesion (1 ). In humans, defects in the genes that participate in NER can lead to a rare recessive disorder, xeroderma pigmentosum (XP). Hypersensitivity to sunlight and a predisposition to skin cancer are the most characteristic traits of XP patients. NER-defective XP cells belong to one of seven genetic complementation groups (A-G). Although the NER process in mammalian cells consistently leads to the excision of damaged DNA fragments 24–32 nucleotides in length, the exact positions of the 5′- and 3′-incisions depend on the lesion being repaired. For instance, during the removal of a thymine dimer, incisions are made at the 22nd–24th phosphodiester bond on the 5′-side of the lesion and at the 5th phosphodiester bond on the 3′-side of the lesion (2 ). The main sites of incision during repair of DNA containing a 1,3-intrastrand d(GpTpG)-cisplatin crosslink are at the 16th–20th phosphodiester bond 5′- and the 8th–9th phosphodiester bond on the 3′-side of the lesion (3 ).
        ad image
        提问
        扫一扫
        丁香实验小程序二维码
        实验小助手
        丁香实验公众号二维码
        扫码领资料
        反馈
        TOP
        打开小程序